nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2A6—lung cancer	0.175	0.48	CbGaD
Desipramine—CYP2E1—lung cancer	0.125	0.341	CbGaD
Desipramine—ABCB1—lung cancer	0.0653	0.179	CbGaD
Desipramine—ORM1—Gefitinib—lung cancer	0.0473	0.124	CbGbCtD
Desipramine—SLC22A3—Irinotecan—lung cancer	0.0353	0.0927	CbGbCtD
Desipramine—ORM1—Erlotinib—lung cancer	0.028	0.0735	CbGbCtD
Desipramine—SLC22A2—Vinblastine—lung cancer	0.0186	0.0488	CbGbCtD
Desipramine—SLC22A2—Cisplatin—lung cancer	0.017	0.0447	CbGbCtD
Desipramine—CYP2C19—Gefitinib—lung cancer	0.0129	0.0339	CbGbCtD
Desipramine—CYP2C19—Teniposide—lung cancer	0.0125	0.0329	CbGbCtD
Desipramine—ABCB1—Topotecan—lung cancer	0.0114	0.0299	CbGbCtD
Desipramine—CYP2B6—Irinotecan—lung cancer	0.0108	0.0285	CbGbCtD
Desipramine—ABCB1—Gefitinib—lung cancer	0.0104	0.0274	CbGbCtD
Desipramine—CYP2D6—Gefitinib—lung cancer	0.00981	0.0258	CbGbCtD
Desipramine—CYP2B6—Cisplatin—lung cancer	0.00884	0.0232	CbGbCtD
Desipramine—CYP2E1—Etoposide—lung cancer	0.0088	0.0231	CbGbCtD
Desipramine—ABCB1—Vinorelbine—lung cancer	0.00802	0.0211	CbGbCtD
Desipramine—CYP2D6—Vinorelbine—lung cancer	0.00755	0.0199	CbGbCtD
Desipramine—CYP1A2—Erlotinib—lung cancer	0.00704	0.0185	CbGbCtD
Desipramine—CYP3A4—Topotecan—lung cancer	0.00682	0.0179	CbGbCtD
Desipramine—ABCB1—Crizotinib—lung cancer	0.00638	0.0168	CbGbCtD
Desipramine—CYP3A4—Gefitinib—lung cancer	0.00624	0.0164	CbGbCtD
Desipramine—ABCB1—Gemcitabine—lung cancer	0.00623	0.0164	CbGbCtD
Desipramine—ABCB1—Erlotinib—lung cancer	0.00615	0.0162	CbGbCtD
Desipramine—CYP3A4—Teniposide—lung cancer	0.00605	0.0159	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—lung cancer	0.00592	0.0156	CbGbCtD
Desipramine—CYP2D6—Erlotinib—lung cancer	0.0058	0.0152	CbGbCtD
Desipramine—ABCB1—Paclitaxel—lung cancer	0.00563	0.0148	CbGbCtD
Desipramine—ABCB1—Irinotecan—lung cancer	0.00556	0.0146	CbGbCtD
Desipramine—CYP1A2—Etoposide—lung cancer	0.00509	0.0134	CbGbCtD
Desipramine—ABCB1—Vinblastine—lung cancer	0.00494	0.013	CbGbCtD
Desipramine—CYP3A4—Vinorelbine—lung cancer	0.0048	0.0126	CbGbCtD
Desipramine—HTR2A—phrenic nerve—lung cancer	0.00477	0.163	CbGeAlD
Desipramine—CYP2D6—Vinblastine—lung cancer	0.00466	0.0122	CbGbCtD
Desipramine—ABCB1—Cisplatin—lung cancer	0.00453	0.0119	CbGbCtD
Desipramine—ABCB1—Etoposide—lung cancer	0.00445	0.0117	CbGbCtD
Desipramine—ABCB1—Docetaxel—lung cancer	0.00407	0.0107	CbGbCtD
Desipramine—CYP3A4—Crizotinib—lung cancer	0.00382	0.01	CbGbCtD
Desipramine—CYP3A4—Erlotinib—lung cancer	0.00369	0.00969	CbGbCtD
Desipramine—CYP3A4—Paclitaxel—lung cancer	0.00337	0.00887	CbGbCtD
Desipramine—CYP3A4—Irinotecan—lung cancer	0.00333	0.00875	CbGbCtD
Desipramine—ABCB1—Doxorubicin—lung cancer	0.00304	0.00798	CbGbCtD
Desipramine—CYP3A4—Vinblastine—lung cancer	0.00296	0.00778	CbGbCtD
Desipramine—ABCB1—Methotrexate—lung cancer	0.00294	0.00773	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—lung cancer	0.00286	0.00752	CbGbCtD
Desipramine—CYP3A4—Etoposide—lung cancer	0.00267	0.00701	CbGbCtD
Desipramine—CYP3A4—Docetaxel—lung cancer	0.00244	0.00641	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—lung cancer	0.00182	0.00478	CbGbCtD
Desipramine—HTR2A—pulmonary artery—lung cancer	0.00173	0.0594	CbGeAlD
Desipramine—SMPD1—respiratory system—lung cancer	0.00132	0.0452	CbGeAlD
Desipramine—SLC22A4—mammary gland—lung cancer	0.000933	0.032	CbGeAlD
Desipramine—SMPD1—cardiac atrium—lung cancer	0.000916	0.0314	CbGeAlD
Desipramine—CYP2C18—bronchus—lung cancer	0.000884	0.0303	CbGeAlD
Desipramine—CHRM5—epithelium—lung cancer	0.000734	0.0251	CbGeAlD
Desipramine—SMPD1—lung—lung cancer	0.000701	0.024	CbGeAlD
Desipramine—SLC22A4—respiratory system—lung cancer	0.000622	0.0213	CbGeAlD
Desipramine—SLC22A5—mammary gland—lung cancer	0.000617	0.0211	CbGeAlD
Desipramine—SLC6A3—respiratory system—lung cancer	0.000601	0.0206	CbGeAlD
Desipramine—SLC6A4—respiratory system—lung cancer	0.000551	0.0189	CbGeAlD
Desipramine—SLC22A4—bronchus—lung cancer	0.000512	0.0175	CbGeAlD
Desipramine—SLC6A2—respiratory system—lung cancer	0.000485	0.0166	CbGeAlD
Desipramine—SMPD1—lymph node—lung cancer	0.000479	0.0164	CbGeAlD
Desipramine—ADRB1—bronchus—lung cancer	0.000469	0.0161	CbGeAlD
Desipramine—SLC22A4—trachea—lung cancer	0.000459	0.0157	CbGeAlD
Desipramine—DRD2—respiratory system—lung cancer	0.000442	0.0151	CbGeAlD
Desipramine—SLC22A5—respiratory system—lung cancer	0.000411	0.0141	CbGeAlD
Desipramine—CHRM1—trachea—lung cancer	0.000405	0.0139	CbGeAlD
Desipramine—ADRB1—cardiac atrium—lung cancer	0.000396	0.0136	CbGeAlD
Desipramine—ORM1—bone marrow—lung cancer	0.000379	0.013	CbGeAlD
Desipramine—CYP2A6—lung—lung cancer	0.000377	0.0129	CbGeAlD
Desipramine—CYP1A2—respiratory system—lung cancer	0.000373	0.0128	CbGeAlD
Desipramine—SLC22A4—bone marrow—lung cancer	0.000364	0.0125	CbGeAlD
Desipramine—CYP2B6—respiratory system—lung cancer	0.000357	0.0122	CbGeAlD
Desipramine—HRH1—respiratory system—lung cancer	0.000349	0.012	CbGeAlD
Desipramine—ORM1—lung—lung cancer	0.000343	0.0118	CbGeAlD
Desipramine—SLC22A5—bronchus—lung cancer	0.000339	0.0116	CbGeAlD
Desipramine—CYP2E1—respiratory system—lung cancer	0.000335	0.0115	CbGeAlD
Desipramine—SLC22A4—lung—lung cancer	0.00033	0.0113	CbGeAlD
Desipramine—SLC6A3—lung—lung cancer	0.000319	0.0109	CbGeAlD
Desipramine—SLC22A5—trachea—lung cancer	0.000304	0.0104	CbGeAlD
Desipramine—ADRB1—lung—lung cancer	0.000303	0.0104	CbGeAlD
Desipramine—SLC22A3—lung—lung cancer	0.0003	0.0103	CbGeAlD
Desipramine—CYP2B6—bronchus—lung cancer	0.000294	0.0101	CbGeAlD
Desipramine—SLC6A4—lung—lung cancer	0.000292	0.01	CbGeAlD
Desipramine—HRH1—epithelium—lung cancer	0.000292	0.00999	CbGeAlD
Desipramine—HTR2A—respiratory system—lung cancer	0.000291	0.00998	CbGeAlD
Desipramine—CHRM1—lung—lung cancer	0.000291	0.00998	CbGeAlD
Desipramine—SLC22A5—cardiac atrium—lung cancer	0.000286	0.00978	CbGeAlD
Desipramine—HRH1—trachea—lung cancer	0.000258	0.00883	CbGeAlD
Desipramine—SLC6A2—lung—lung cancer	0.000257	0.00882	CbGeAlD
Desipramine—HTR2A—epithelium—lung cancer	0.000244	0.00834	CbGeAlD
Desipramine—ORM1—lymph node—lung cancer	0.000235	0.00804	CbGeAlD
Desipramine—DRD2—lung—lung cancer	0.000235	0.00804	CbGeAlD
Desipramine—SLC22A4—lymph node—lung cancer	0.000226	0.00774	CbGeAlD
Desipramine—SLC22A5—lung—lung cancer	0.000218	0.00748	CbGeAlD
Desipramine—HTR2A—trachea—lung cancer	0.000215	0.00738	CbGeAlD
Desipramine—SLC22A3—lymph node—lung cancer	0.000205	0.00704	CbGeAlD
Desipramine—CYP1A2—lung—lung cancer	0.000198	0.00678	CbGeAlD
Desipramine—ABCB1—respiratory system—lung cancer	0.000191	0.00654	CbGeAlD
Desipramine—CYP2B6—lung—lung cancer	0.00019	0.0065	CbGeAlD
Desipramine—Clomipramine—GSTP1—lung cancer	0.000188	0.122	CrCbGaD
Desipramine—HRH1—lung—lung cancer	0.000185	0.00635	CbGeAlD
Desipramine—CYP2E1—lung—lung cancer	0.000178	0.0061	CbGeAlD
Desipramine—SLC6A2—lymph node—lung cancer	0.000176	0.00603	CbGeAlD
Desipramine—ABCB1—epithelium—lung cancer	0.00016	0.00547	CbGeAlD
Desipramine—HTR2A—lung—lung cancer	0.000155	0.0053	CbGeAlD
Desipramine—SLC22A5—lymph node—lung cancer	0.000149	0.00512	CbGeAlD
Desipramine—ABCB1—trachea—lung cancer	0.000141	0.00483	CbGeAlD
Desipramine—Protriptyline—ABCB1—lung cancer	0.000129	0.0833	CrCbGaD
Desipramine—HRH1—lymph node—lung cancer	0.000127	0.00434	CbGeAlD
Desipramine—Vomiting—Topotecan—lung cancer	0.00012	0.00107	CcSEcCtD
Desipramine—Malaise—Paclitaxel—lung cancer	0.00012	0.00107	CcSEcCtD
Desipramine—Paraesthesia—Irinotecan—lung cancer	0.000119	0.00106	CcSEcCtD
Desipramine—Cerebrovascular accident—Doxorubicin—lung cancer	0.000119	0.00106	CcSEcCtD
Desipramine—Rash—Topotecan—lung cancer	0.000119	0.00106	CcSEcCtD
Desipramine—Dermatitis—Topotecan—lung cancer	0.000118	0.00106	CcSEcCtD
Desipramine—Vomiting—Erlotinib—lung cancer	0.000118	0.00106	CcSEcCtD
Desipramine—Somnolence—Irinotecan—lung cancer	0.000118	0.00105	CcSEcCtD
Desipramine—Thrombocytopenia—Cisplatin—lung cancer	0.000118	0.00105	CcSEcCtD
Desipramine—Headache—Topotecan—lung cancer	0.000118	0.00105	CcSEcCtD
Desipramine—Tachycardia—Cisplatin—lung cancer	0.000118	0.00105	CcSEcCtD
Desipramine—Rash—Erlotinib—lung cancer	0.000117	0.00105	CcSEcCtD
Desipramine—Dermatitis—Erlotinib—lung cancer	0.000117	0.00105	CcSEcCtD
Desipramine—Palpitations—Paclitaxel—lung cancer	0.000117	0.00105	CcSEcCtD
Desipramine—Convulsion—Etoposide—lung cancer	0.000117	0.00105	CcSEcCtD
Desipramine—Insomnia—Gemcitabine—lung cancer	0.000117	0.00104	CcSEcCtD
Desipramine—Dyspepsia—Irinotecan—lung cancer	0.000117	0.00104	CcSEcCtD
Desipramine—Hypertension—Etoposide—lung cancer	0.000117	0.00104	CcSEcCtD
Desipramine—Headache—Erlotinib—lung cancer	0.000117	0.00104	CcSEcCtD
Desipramine—Paraesthesia—Gemcitabine—lung cancer	0.000116	0.00104	CcSEcCtD
Desipramine—Asthenia—Vinorelbine—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Decreased appetite—Irinotecan—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Arrhythmia—Docetaxel—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Eosinophilia—Methotrexate—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Nausea—Vinblastine—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Somnolence—Gemcitabine—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Convulsion—Paclitaxel—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Anorexia—Cisplatin—lung cancer	0.000115	0.00103	CcSEcCtD
Desipramine—Hypertension—Paclitaxel—lung cancer	0.000114	0.00102	CcSEcCtD
Desipramine—Fatigue—Irinotecan—lung cancer	0.000114	0.00102	CcSEcCtD
Desipramine—Alopecia—Docetaxel—lung cancer	0.000114	0.00102	CcSEcCtD
Desipramine—Pruritus—Vinorelbine—lung cancer	0.000114	0.00102	CcSEcCtD
Desipramine—Discomfort—Etoposide—lung cancer	0.000114	0.00102	CcSEcCtD
Desipramine—Constipation—Irinotecan—lung cancer	0.000113	0.00101	CcSEcCtD
Desipramine—Hypotension—Cisplatin—lung cancer	0.000113	0.00101	CcSEcCtD
Desipramine—Anxiety—Paclitaxel—lung cancer	0.000112	0.00101	CcSEcCtD
Desipramine—Decreased appetite—Gemcitabine—lung cancer	0.000112	0.001	CcSEcCtD
Desipramine—ABCB1—bone marrow—lung cancer	0.000112	0.00383	CbGeAlD
Desipramine—Nausea—Topotecan—lung cancer	0.000112	0.000999	CcSEcCtD
Desipramine—Discomfort—Paclitaxel—lung cancer	0.000112	0.000997	CcSEcCtD
Desipramine—Fatigue—Gemcitabine—lung cancer	0.000111	0.000996	CcSEcCtD
Desipramine—Confusional state—Etoposide—lung cancer	0.000111	0.000995	CcSEcCtD
Desipramine—Constipation—Gemcitabine—lung cancer	0.000111	0.000988	CcSEcCtD
Desipramine—Nausea—Erlotinib—lung cancer	0.000111	0.000988	CcSEcCtD
Desipramine—Dry mouth—Paclitaxel—lung cancer	0.00011	0.000987	CcSEcCtD
Desipramine—Diarrhoea—Vinorelbine—lung cancer	0.00011	0.000984	CcSEcCtD
Desipramine—Dysgeusia—Docetaxel—lung cancer	0.00011	0.000984	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—lung cancer	0.00011	0.000979	CcSEcCtD
Desipramine—Feeling abnormal—Irinotecan—lung cancer	0.000109	0.000977	CcSEcCtD
Desipramine—Confusional state—Paclitaxel—lung cancer	0.000109	0.000975	CcSEcCtD
Desipramine—Oedema—Paclitaxel—lung cancer	0.000108	0.000967	CcSEcCtD
Desipramine—Paraesthesia—Cisplatin—lung cancer	0.000108	0.000967	CcSEcCtD
Desipramine—Thrombocytopenia—Etoposide—lung cancer	0.000108	0.000966	CcSEcCtD
Desipramine—Tachycardia—Etoposide—lung cancer	0.000108	0.000963	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—lung cancer	0.000108	0.000961	CcSEcCtD
Desipramine—Erectile dysfunction—Methotrexate—lung cancer	0.000107	0.000957	CcSEcCtD
Desipramine—Feeling abnormal—Gemcitabine—lung cancer	0.000107	0.000952	CcSEcCtD
Desipramine—Dizziness—Vinorelbine—lung cancer	0.000106	0.000951	CcSEcCtD
Desipramine—Thrombocytopenia—Paclitaxel—lung cancer	0.000106	0.000947	CcSEcCtD
Desipramine—Tachycardia—Paclitaxel—lung cancer	0.000106	0.000944	CcSEcCtD
Desipramine—Anorexia—Etoposide—lung cancer	0.000105	0.00094	CcSEcCtD
Desipramine—Abdominal pain—Irinotecan—lung cancer	0.000105	0.000938	CcSEcCtD
Desipramine—Body temperature increased—Irinotecan—lung cancer	0.000105	0.000938	CcSEcCtD
Desipramine—Decreased appetite—Cisplatin—lung cancer	0.000105	0.000936	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—lung cancer	0.000104	0.000927	CcSEcCtD
Desipramine—Depression—Methotrexate—lung cancer	0.000103	0.000924	CcSEcCtD
Desipramine—Anorexia—Paclitaxel—lung cancer	0.000103	0.000922	CcSEcCtD
Desipramine—Hypotension—Etoposide—lung cancer	0.000103	0.000922	CcSEcCtD
Desipramine—Vomiting—Vinorelbine—lung cancer	0.000102	0.000914	CcSEcCtD
Desipramine—Body temperature increased—Gemcitabine—lung cancer	0.000102	0.000913	CcSEcCtD
Desipramine—Rash—Vinorelbine—lung cancer	0.000101	0.000907	CcSEcCtD
Desipramine—ABCB1—lung—lung cancer	0.000101	0.00347	CbGeAlD
Desipramine—Dermatitis—Vinorelbine—lung cancer	0.000101	0.000906	CcSEcCtD
Desipramine—Hypotension—Paclitaxel—lung cancer	0.000101	0.000904	CcSEcCtD
Desipramine—Stomatitis—Methotrexate—lung cancer	0.000101	0.000903	CcSEcCtD
Desipramine—Headache—Vinorelbine—lung cancer	0.000101	0.000901	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—lung cancer	9.97e-05	0.000891	CcSEcCtD
Desipramine—Palpitations—Docetaxel—lung cancer	9.93e-05	0.000888	CcSEcCtD
Desipramine—Feeling abnormal—Cisplatin—lung cancer	9.93e-05	0.000887	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—lung cancer	9.91e-05	0.000886	CcSEcCtD
Desipramine—Somnolence—Etoposide—lung cancer	9.81e-05	0.000877	CcSEcCtD
Desipramine—Insomnia—Paclitaxel—lung cancer	9.79e-05	0.000875	CcSEcCtD
Desipramine—Convulsion—Docetaxel—lung cancer	9.74e-05	0.00087	CcSEcCtD
Desipramine—Paraesthesia—Paclitaxel—lung cancer	9.72e-05	0.000869	CcSEcCtD
Desipramine—Hypertension—Docetaxel—lung cancer	9.7e-05	0.000867	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—lung cancer	9.67e-05	0.000865	CcSEcCtD
Desipramine—Somnolence—Paclitaxel—lung cancer	9.62e-05	0.00086	CcSEcCtD
Desipramine—Decreased appetite—Etoposide—lung cancer	9.59e-05	0.000858	CcSEcCtD
Desipramine—Epinastine—ABCB1—lung cancer	9.57e-05	0.0618	CrCbGaD
Desipramine—Nausea—Vinorelbine—lung cancer	9.56e-05	0.000854	CcSEcCtD
Desipramine—Dyspepsia—Paclitaxel—lung cancer	9.53e-05	0.000851	CcSEcCtD
Desipramine—Body temperature increased—Cisplatin—lung cancer	9.52e-05	0.000851	CcSEcCtD
Desipramine—Asthenia—Irinotecan—lung cancer	9.52e-05	0.000851	CcSEcCtD
Desipramine—Fatigue—Etoposide—lung cancer	9.52e-05	0.000851	CcSEcCtD
Desipramine—Constipation—Etoposide—lung cancer	9.44e-05	0.000844	CcSEcCtD
Desipramine—Nortriptyline—CYP2E1—lung cancer	9.44e-05	0.0609	CrCbGaD
Desipramine—Decreased appetite—Paclitaxel—lung cancer	9.41e-05	0.000841	CcSEcCtD
Desipramine—Dry mouth—Docetaxel—lung cancer	9.36e-05	0.000836	CcSEcCtD
Desipramine—Fatigue—Paclitaxel—lung cancer	9.33e-05	0.000834	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—lung cancer	9.3e-05	0.000832	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—lung cancer	9.3e-05	0.000831	CcSEcCtD
Desipramine—Asthenia—Gemcitabine—lung cancer	9.27e-05	0.000829	CcSEcCtD
Desipramine—Constipation—Paclitaxel—lung cancer	9.25e-05	0.000827	CcSEcCtD
Desipramine—Confusional state—Docetaxel—lung cancer	9.25e-05	0.000827	CcSEcCtD
Desipramine—Oxcarbazepine—ALB—lung cancer	9.24e-05	0.0596	CrCbGaD
Desipramine—Oedema—Docetaxel—lung cancer	9.17e-05	0.00082	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—lung cancer	9.16e-05	0.000819	CcSEcCtD
Desipramine—Pruritus—Gemcitabine—lung cancer	9.14e-05	0.000817	CcSEcCtD
Desipramine—Feeling abnormal—Etoposide—lung cancer	9.09e-05	0.000813	CcSEcCtD
Desipramine—Diarrhoea—Irinotecan—lung cancer	9.08e-05	0.000811	CcSEcCtD
Desipramine—Thrombocytopenia—Docetaxel—lung cancer	8.98e-05	0.000803	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—lung cancer	8.98e-05	0.000802	CcSEcCtD
Desipramine—Tachycardia—Docetaxel—lung cancer	8.95e-05	0.0008	CcSEcCtD
Desipramine—Feeling abnormal—Paclitaxel—lung cancer	8.92e-05	0.000797	CcSEcCtD
Desipramine—Diarrhoea—Gemcitabine—lung cancer	8.84e-05	0.00079	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—lung cancer	8.8e-05	0.000786	CcSEcCtD
Desipramine—Dizziness—Irinotecan—lung cancer	8.77e-05	0.000784	CcSEcCtD
Desipramine—Urticaria—Etoposide—lung cancer	8.77e-05	0.000784	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—lung cancer	8.75e-05	0.000782	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—lung cancer	8.75e-05	0.000782	CcSEcCtD
Desipramine—Anorexia—Docetaxel—lung cancer	8.74e-05	0.000782	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—lung cancer	8.72e-05	0.00078	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—lung cancer	8.72e-05	0.00078	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—lung cancer	8.68e-05	0.000775	CcSEcCtD
Desipramine—Asthenia—Cisplatin—lung cancer	8.64e-05	0.000773	CcSEcCtD
Desipramine—Urticaria—Paclitaxel—lung cancer	8.6e-05	0.000768	CcSEcCtD
Desipramine—Hypotension—Docetaxel—lung cancer	8.57e-05	0.000766	CcSEcCtD
Desipramine—Abdominal pain—Paclitaxel—lung cancer	8.55e-05	0.000765	CcSEcCtD
Desipramine—Body temperature increased—Paclitaxel—lung cancer	8.55e-05	0.000765	CcSEcCtD
Desipramine—Vomiting—Irinotecan—lung cancer	8.44e-05	0.000754	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—lung cancer	8.38e-05	0.000749	CcSEcCtD
Desipramine—Rash—Irinotecan—lung cancer	8.37e-05	0.000748	CcSEcCtD
Desipramine—Dermatitis—Irinotecan—lung cancer	8.36e-05	0.000747	CcSEcCtD
Desipramine—Headache—Irinotecan—lung cancer	8.31e-05	0.000743	CcSEcCtD
Desipramine—Insomnia—Docetaxel—lung cancer	8.3e-05	0.000742	CcSEcCtD
Desipramine—Diarrhoea—Cisplatin—lung cancer	8.24e-05	0.000737	CcSEcCtD
Desipramine—Paraesthesia—Docetaxel—lung cancer	8.24e-05	0.000736	CcSEcCtD
Desipramine—Maprotiline—ABCB1—lung cancer	8.24e-05	0.0532	CrCbGaD
Desipramine—Alopecia—Methotrexate—lung cancer	8.22e-05	0.000735	CcSEcCtD
Desipramine—Vomiting—Gemcitabine—lung cancer	8.22e-05	0.000735	CcSEcCtD
Desipramine—Somnolence—Docetaxel—lung cancer	8.15e-05	0.000729	CcSEcCtD
Desipramine—Rash—Gemcitabine—lung cancer	8.15e-05	0.000728	CcSEcCtD
Desipramine—Dermatitis—Gemcitabine—lung cancer	8.14e-05	0.000728	CcSEcCtD
Desipramine—Headache—Gemcitabine—lung cancer	8.1e-05	0.000724	CcSEcCtD
Desipramine—Dyspepsia—Docetaxel—lung cancer	8.07e-05	0.000722	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—lung cancer	8.06e-05	0.00072	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—lung cancer	8.02e-05	0.000717	CcSEcCtD
Desipramine—Decreased appetite—Docetaxel—lung cancer	7.97e-05	0.000713	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—lung cancer	7.93e-05	0.000709	CcSEcCtD
Desipramine—Asthenia—Etoposide—lung cancer	7.92e-05	0.000708	CcSEcCtD
Desipramine—Fatigue—Docetaxel—lung cancer	7.91e-05	0.000707	CcSEcCtD
Desipramine—Nausea—Irinotecan—lung cancer	7.88e-05	0.000704	CcSEcCtD
Desipramine—Constipation—Docetaxel—lung cancer	7.84e-05	0.000701	CcSEcCtD
Desipramine—Pruritus—Etoposide—lung cancer	7.81e-05	0.000698	CcSEcCtD
Desipramine—Asthenia—Paclitaxel—lung cancer	7.76e-05	0.000694	CcSEcCtD
Desipramine—Nausea—Gemcitabine—lung cancer	7.68e-05	0.000686	CcSEcCtD
Desipramine—Vomiting—Cisplatin—lung cancer	7.66e-05	0.000685	CcSEcCtD
Desipramine—Pruritus—Paclitaxel—lung cancer	7.66e-05	0.000684	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—lung cancer	7.63e-05	0.000682	CcSEcCtD
Desipramine—Rash—Cisplatin—lung cancer	7.6e-05	0.000679	CcSEcCtD
Desipramine—Dermatitis—Cisplatin—lung cancer	7.59e-05	0.000678	CcSEcCtD
Desipramine—Feeling abnormal—Docetaxel—lung cancer	7.56e-05	0.000676	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—lung cancer	7.55e-05	0.000675	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—lung cancer	7.52e-05	0.000672	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—lung cancer	7.51e-05	0.000671	CcSEcCtD
Desipramine—Flushing—Doxorubicin—lung cancer	7.48e-05	0.000668	CcSEcCtD
Desipramine—Diarrhoea—Paclitaxel—lung cancer	7.4e-05	0.000662	CcSEcCtD
Desipramine—Malaise—Methotrexate—lung cancer	7.3e-05	0.000653	CcSEcCtD
Desipramine—Dizziness—Etoposide—lung cancer	7.3e-05	0.000652	CcSEcCtD
Desipramine—Abdominal pain—Docetaxel—lung cancer	7.25e-05	0.000648	CcSEcCtD
Desipramine—Body temperature increased—Docetaxel—lung cancer	7.25e-05	0.000648	CcSEcCtD
Desipramine—Triflupromazine—ABCB1—lung cancer	7.2e-05	0.0465	CrCbGaD
Desipramine—Arrhythmia—Doxorubicin—lung cancer	7.2e-05	0.000643	CcSEcCtD
Desipramine—Dizziness—Paclitaxel—lung cancer	7.16e-05	0.00064	CcSEcCtD
Desipramine—Nausea—Cisplatin—lung cancer	7.16e-05	0.00064	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—lung cancer	7.12e-05	0.000636	CcSEcCtD
Desipramine—Convulsion—Methotrexate—lung cancer	7.02e-05	0.000627	CcSEcCtD
Desipramine—Vomiting—Etoposide—lung cancer	7.02e-05	0.000627	CcSEcCtD
Desipramine—Acepromazine—ALB—lung cancer	6.98e-05	0.0451	CrCbGaD
Desipramine—Rash—Etoposide—lung cancer	6.96e-05	0.000622	CcSEcCtD
Desipramine—Dermatitis—Etoposide—lung cancer	6.95e-05	0.000621	CcSEcCtD
Desipramine—ABCB1—lymph node—lung cancer	6.93e-05	0.00238	CbGeAlD
Desipramine—Headache—Etoposide—lung cancer	6.91e-05	0.000618	CcSEcCtD
Desipramine—Vomiting—Paclitaxel—lung cancer	6.88e-05	0.000615	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—lung cancer	6.87e-05	0.000614	CcSEcCtD
Desipramine—Rash—Paclitaxel—lung cancer	6.82e-05	0.00061	CcSEcCtD
Desipramine—Dermatitis—Paclitaxel—lung cancer	6.82e-05	0.000609	CcSEcCtD
Desipramine—Discomfort—Methotrexate—lung cancer	6.81e-05	0.000609	CcSEcCtD
Desipramine—Headache—Paclitaxel—lung cancer	6.78e-05	0.000606	CcSEcCtD
Desipramine—Confusional state—Methotrexate—lung cancer	6.67e-05	0.000596	CcSEcCtD
Desipramine—Chlorpromazine—CYP2E1—lung cancer	6.62e-05	0.0428	CrCbGaD
Desipramine—Vision blurred—Doxorubicin—lung cancer	6.61e-05	0.000591	CcSEcCtD
Desipramine—Imipramine—CYP2E1—lung cancer	6.59e-05	0.0425	CrCbGaD
Desipramine—Asthenia—Docetaxel—lung cancer	6.58e-05	0.000588	CcSEcCtD
Desipramine—Nausea—Etoposide—lung cancer	6.56e-05	0.000586	CcSEcCtD
Desipramine—Amitriptyline—CYP2E1—lung cancer	6.55e-05	0.0423	CrCbGaD
Desipramine—Ill-defined disorder—Doxorubicin—lung cancer	6.51e-05	0.000582	CcSEcCtD
Desipramine—Pruritus—Docetaxel—lung cancer	6.49e-05	0.00058	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—lung cancer	6.47e-05	0.000579	CcSEcCtD
Desipramine—Agitation—Doxorubicin—lung cancer	6.45e-05	0.000576	CcSEcCtD
Desipramine—Nausea—Paclitaxel—lung cancer	6.43e-05	0.000575	CcSEcCtD
Desipramine—Malaise—Doxorubicin—lung cancer	6.33e-05	0.000565	CcSEcCtD
Desipramine—Anorexia—Methotrexate—lung cancer	6.3e-05	0.000563	CcSEcCtD
Desipramine—Diarrhoea—Docetaxel—lung cancer	6.28e-05	0.000561	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—lung cancer	6.2e-05	0.000554	CcSEcCtD
Desipramine—Hypotension—Methotrexate—lung cancer	6.18e-05	0.000552	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—lung cancer	6.08e-05	0.000543	CcSEcCtD
Desipramine—Dizziness—Docetaxel—lung cancer	6.07e-05	0.000542	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—lung cancer	6.06e-05	0.000541	CcSEcCtD
Desipramine—Carbamazepine—ABCB1—lung cancer	6.01e-05	0.0388	CrCbGaD
Desipramine—Insomnia—Methotrexate—lung cancer	5.98e-05	0.000534	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—lung cancer	5.95e-05	0.000532	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—lung cancer	5.94e-05	0.000531	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—lung cancer	5.9e-05	0.000527	CcSEcCtD
Desipramine—Somnolence—Methotrexate—lung cancer	5.88e-05	0.000525	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—lung cancer	5.84e-05	0.000522	CcSEcCtD
Desipramine—Vomiting—Docetaxel—lung cancer	5.83e-05	0.000521	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—lung cancer	5.82e-05	0.00052	CcSEcCtD
Desipramine—Rash—Docetaxel—lung cancer	5.78e-05	0.000517	CcSEcCtD
Desipramine—Dermatitis—Docetaxel—lung cancer	5.78e-05	0.000516	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—lung cancer	5.77e-05	0.000516	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—lung cancer	5.75e-05	0.000514	CcSEcCtD
Desipramine—Headache—Docetaxel—lung cancer	5.75e-05	0.000514	CcSEcCtD
Desipramine—Oedema—Doxorubicin—lung cancer	5.72e-05	0.000512	CcSEcCtD
Desipramine—Fatigue—Methotrexate—lung cancer	5.7e-05	0.000509	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—lung cancer	5.6e-05	0.000501	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—lung cancer	5.59e-05	0.000499	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—lung cancer	5.46e-05	0.000488	CcSEcCtD
Desipramine—Nausea—Docetaxel—lung cancer	5.45e-05	0.000487	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—lung cancer	5.45e-05	0.000487	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—lung cancer	5.35e-05	0.000478	CcSEcCtD
Desipramine—Clomipramine—ALB—lung cancer	5.3e-05	0.0342	CrCbGaD
Desipramine—Urticaria—Methotrexate—lung cancer	5.25e-05	0.000469	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—lung cancer	5.23e-05	0.000467	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—lung cancer	5.23e-05	0.000467	CcSEcCtD
Desipramine—Nortriptyline—ALB—lung cancer	5.18e-05	0.0335	CrCbGaD
Desipramine—Insomnia—Doxorubicin—lung cancer	5.18e-05	0.000463	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—lung cancer	5.14e-05	0.000459	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—lung cancer	5.09e-05	0.000455	CcSEcCtD
Desipramine—Clomipramine—ABCB1—lung cancer	5.06e-05	0.0327	CrCbGaD
Desipramine—Dyspepsia—Doxorubicin—lung cancer	5.04e-05	0.00045	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—lung cancer	4.98e-05	0.000445	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—lung cancer	4.94e-05	0.000441	CcSEcCtD
Desipramine—Constipation—Doxorubicin—lung cancer	4.9e-05	0.000438	CcSEcCtD
Desipramine—Asthenia—Methotrexate—lung cancer	4.74e-05	0.000424	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—lung cancer	4.72e-05	0.000422	CcSEcCtD
Desipramine—Pruritus—Methotrexate—lung cancer	4.68e-05	0.000418	CcSEcCtD
Desipramine—Trimipramine—ABCB1—lung cancer	4.66e-05	0.0301	CrCbGaD
Desipramine—Urticaria—Doxorubicin—lung cancer	4.55e-05	0.000406	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—lung cancer	4.53e-05	0.000404	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—lung cancer	4.53e-05	0.000404	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—lung cancer	4.52e-05	0.000404	CcSEcCtD
Desipramine—Promethazine—ABCB1—lung cancer	4.48e-05	0.029	CrCbGaD
Desipramine—Doxepin—ABCB1—lung cancer	4.44e-05	0.0287	CrCbGaD
Desipramine—Dizziness—Methotrexate—lung cancer	4.37e-05	0.000391	CcSEcCtD
Desipramine—Vomiting—Methotrexate—lung cancer	4.2e-05	0.000376	CcSEcCtD
Desipramine—Rash—Methotrexate—lung cancer	4.17e-05	0.000373	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—lung cancer	4.16e-05	0.000372	CcSEcCtD
Desipramine—Headache—Methotrexate—lung cancer	4.14e-05	0.00037	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—lung cancer	4.11e-05	0.000367	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—lung cancer	4.05e-05	0.000362	CcSEcCtD
Desipramine—Nausea—Methotrexate—lung cancer	3.93e-05	0.000351	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—lung cancer	3.92e-05	0.00035	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—lung cancer	3.79e-05	0.000338	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—lung cancer	3.64e-05	0.000325	CcSEcCtD
Desipramine—Chlorpromazine—ALB—lung cancer	3.64e-05	0.0235	CrCbGaD
Desipramine—Rash—Doxorubicin—lung cancer	3.61e-05	0.000323	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—lung cancer	3.61e-05	0.000322	CcSEcCtD
Desipramine—Amitriptyline—ALB—lung cancer	3.6e-05	0.0232	CrCbGaD
Desipramine—Headache—Doxorubicin—lung cancer	3.59e-05	0.000321	CcSEcCtD
Desipramine—Chlorpromazine—ABCB1—lung cancer	3.47e-05	0.0224	CrCbGaD
Desipramine—Imipramine—ABCB1—lung cancer	3.45e-05	0.0223	CrCbGaD
Desipramine—Amitriptyline—ABCB1—lung cancer	3.43e-05	0.0222	CrCbGaD
Desipramine—Nausea—Doxorubicin—lung cancer	3.4e-05	0.000304	CcSEcCtD
Desipramine—CHRM1—Signaling by GPCR—IL6—lung cancer	1.61e-06	1.44e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JUN—lung cancer	1.61e-06	1.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—lung cancer	1.6e-06	1.44e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.6e-06	1.43e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—lung cancer	1.6e-06	1.43e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—lung cancer	1.6e-06	1.43e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—lung cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—lung cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—lung cancer	1.59e-06	1.42e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—lung cancer	1.59e-06	1.42e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—lung cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—lung cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—lung cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—lung cancer	1.58e-06	1.42e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—lung cancer	1.58e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—lung cancer	1.58e-06	1.41e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—lung cancer	1.58e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—lung cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—lung cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—lung cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—lung cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—lung cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—lung cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—lung cancer	1.56e-06	1.4e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—lung cancer	1.56e-06	1.4e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—POMC—lung cancer	1.56e-06	1.4e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.56e-06	1.4e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—lung cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—lung cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—lung cancer	1.55e-06	1.39e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.55e-06	1.39e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—lung cancer	1.55e-06	1.38e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—lung cancer	1.54e-06	1.38e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—lung cancer	1.54e-06	1.38e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—lung cancer	1.54e-06	1.38e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—lung cancer	1.54e-06	1.38e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAT—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—lung cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—lung cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOA1—lung cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CREBBP—lung cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—lung cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—lung cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.51e-06	1.36e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—lung cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—lung cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK3—lung cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—lung cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—lung cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—lung cancer	1.5e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.49e-06	1.34e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—lung cancer	1.49e-06	1.33e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—lung cancer	1.49e-06	1.33e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—lung cancer	1.49e-06	1.33e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—lung cancer	1.49e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.49e-06	1.33e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—lung cancer	1.48e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.48e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—lung cancer	1.48e-06	1.32e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—lung cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—lung cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—lung cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.47e-06	1.31e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—lung cancer	1.46e-06	1.31e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TYMS—lung cancer	1.46e-06	1.31e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—lung cancer	1.46e-06	1.31e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—lung cancer	1.46e-06	1.31e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—lung cancer	1.46e-06	1.3e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.46e-06	1.3e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—lung cancer	1.45e-06	1.3e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—lung cancer	1.45e-06	1.3e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—lung cancer	1.44e-06	1.29e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—lung cancer	1.44e-06	1.29e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.44e-06	1.29e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—lung cancer	1.44e-06	1.29e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—lung cancer	1.43e-06	1.28e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—lung cancer	1.43e-06	1.28e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—lung cancer	1.42e-06	1.27e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—lung cancer	1.42e-06	1.27e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—lung cancer	1.42e-06	1.27e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—lung cancer	1.42e-06	1.27e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—lung cancer	1.41e-06	1.26e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—lung cancer	1.41e-06	1.26e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—lung cancer	1.41e-06	1.26e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—lung cancer	1.41e-06	1.26e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—lung cancer	1.4e-06	1.26e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—lung cancer	1.39e-06	1.25e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—lung cancer	1.39e-06	1.25e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—lung cancer	1.39e-06	1.25e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—lung cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—lung cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.38e-06	1.24e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—lung cancer	1.38e-06	1.24e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.38e-06	1.23e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.37e-06	1.23e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—lung cancer	1.37e-06	1.23e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.37e-06	1.23e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—lung cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—lung cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—lung cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—lung cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ERCC2—lung cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—lung cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—lung cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—lung cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—lung cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.34e-06	1.2e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.34e-06	1.2e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—lung cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK3—lung cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—POMC—lung cancer	1.32e-06	1.18e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—lung cancer	1.32e-06	1.18e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.31e-06	1.17e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.31e-06	1.17e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.3e-06	1.17e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—lung cancer	1.3e-06	1.17e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.3e-06	1.16e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.3e-06	1.16e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—lung cancer	1.29e-06	1.16e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CREBBP—lung cancer	1.29e-06	1.15e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.28e-06	1.15e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—lung cancer	1.28e-06	1.15e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.28e-06	1.14e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—lung cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—lung cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—lung cancer	1.27e-06	1.13e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—lung cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—lung cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—lung cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.26e-06	1.12e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.25e-06	1.12e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—lung cancer	1.25e-06	1.12e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—lung cancer	1.25e-06	1.12e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—lung cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—lung cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—lung cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—lung cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—lung cancer	1.23e-06	1.1e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.22e-06	1.09e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.22e-06	1.09e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—lung cancer	1.21e-06	1.09e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—lung cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—lung cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—lung cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—lung cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—lung cancer	1.19e-06	1.07e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—lung cancer	1.18e-06	1.06e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—lung cancer	1.18e-06	1.06e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—lung cancer	1.18e-06	1.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOA1—lung cancer	1.17e-06	1.05e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—lung cancer	1.17e-06	1.05e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.17e-06	1.05e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—lung cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—lung cancer	1.16e-06	1.04e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—lung cancer	1.16e-06	1.04e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—lung cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—lung cancer	1.13e-06	1.01e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—lung cancer	1.13e-06	1.01e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—lung cancer	1.13e-06	1.01e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—lung cancer	1.12e-06	9.99e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—lung cancer	1.11e-06	9.91e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—lung cancer	1.1e-06	9.86e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—lung cancer	1.1e-06	9.86e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—lung cancer	1.1e-06	9.84e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.1e-06	9.83e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—lung cancer	1.09e-06	9.72e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.08e-06	9.67e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—lung cancer	1.08e-06	9.66e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.08e-06	9.65e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.07e-06	9.62e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.07e-06	9.6e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.07e-06	9.59e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—lung cancer	1.07e-06	9.56e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.06e-06	9.53e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—lung cancer	1.06e-06	9.51e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.06e-06	9.49e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—lung cancer	1.05e-06	9.44e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—lung cancer	1.05e-06	9.37e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—lung cancer	1.04e-06	9.36e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—lung cancer	1.04e-06	9.35e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—lung cancer	1.04e-06	9.33e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—lung cancer	1.04e-06	9.3e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—lung cancer	1.04e-06	9.28e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—lung cancer	1.03e-06	9.27e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—lung cancer	1.03e-06	9.19e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.02e-06	9.14e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—POMC—lung cancer	1.02e-06	9.13e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.02e-06	9.1e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—lung cancer	1.02e-06	9.09e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—lung cancer	9.99e-07	8.95e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—lung cancer	9.97e-07	8.93e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—lung cancer	9.94e-07	8.9e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CREBBP—lung cancer	9.93e-07	8.9e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—lung cancer	9.9e-07	8.87e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—lung cancer	9.81e-07	8.78e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—lung cancer	9.72e-07	8.7e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—lung cancer	9.56e-07	8.56e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—lung cancer	9.54e-07	8.54e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—lung cancer	9.51e-07	8.52e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—lung cancer	9.48e-07	8.49e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—lung cancer	9.42e-07	8.44e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—lung cancer	9.39e-07	8.41e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—lung cancer	9.3e-07	8.33e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—lung cancer	9.19e-07	8.23e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—lung cancer	9e-07	8.06e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—lung cancer	8.96e-07	8.03e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—lung cancer	8.82e-07	7.9e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—lung cancer	8.81e-07	7.89e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—lung cancer	8.8e-07	7.88e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—lung cancer	8.77e-07	7.86e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—lung cancer	8.77e-07	7.85e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—lung cancer	8.75e-07	7.83e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—lung cancer	8.66e-07	7.76e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—lung cancer	8.32e-07	7.45e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—lung cancer	8.21e-07	7.35e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—lung cancer	8.14e-07	7.29e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—lung cancer	8.12e-07	7.28e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—lung cancer	7.66e-07	6.86e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—lung cancer	7.09e-07	6.35e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—lung cancer	6.8e-07	6.09e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—lung cancer	6.77e-07	6.06e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—lung cancer	6.64e-07	5.94e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—lung cancer	6.49e-07	5.81e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—lung cancer	6.25e-07	5.6e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—lung cancer	5.3e-07	4.74e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—lung cancer	5.01e-07	4.48e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—lung cancer	4.09e-07	3.66e-06	CbGpPWpGaD
